May 20, 2025 04:11 PM EDTUpdated 05:10 PM

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Zachary Brennan

Senior Editor

The FDA’s Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genentech’s pivotal trial is applicable to the US patient population for a Columvi …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

RFK Jr. spars with senators over research cuts, HHS budget plan

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answer

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Up­dat­ed: FDA ad­comm splits votes on Genen­tech and J&J can­cer drugs

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Up­dat­ed: Trump ad­min­is­tra­tion re­veals 'most fa­vored na­tion' drug price coun­try tar­gets

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

RFK Jr. spars with sen­a­tors over re­search cuts, HHS bud­get plan

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

CRISPR Ther­a­peu­tics part­ners with siR­NA com­pa­ny, show­ing that gene edit­ing isn’t the on­ly an­swer

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

RFK Jr. spars with senators over research cuts, HHS budget plan

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answer

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?